Items where authors include "Gill, L."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Lu, Y. orcid.org/0000-0002-9848-3308, Xiao, K. orcid.org/0000-0001-7197-7159, Pointer, M. et al. (15 more authors) (2025) The International Skin Spectra Archive (ISSA): a multicultural human skin phenotype and colour spectra collection. Scientific Data, 12. 487. ISSN 2052-4463

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Brown, H.D.H. orcid.org/0000-0001-5128-9172, Gouws, A.D., Vernon, R.J.W. et al. (6 more authors) (2021) Assessing functional reorganization in visual cortex with simulated retinal lesions. Brain Structure and Function, 226. pp. 2855-2867. ISSN 1863-2653

Wild, T., Henneberry, J.M. orcid.org/0000-0002-3563-4957 and Gill, L. (2017) Comprehending the multiple 'values' of green infrastructure - valuing nature-based solutions for urban water management, from multiple perspectives. Environmental Research, 158. pp. 179-187. ISSN 0013-9351

Gill, L. and Lange, E. orcid.org/0000-0002-2917-697X (2015) Getting virtual 3D landscapes out of the lab. Computers, Environment and Urban Systems, 54. pp. 356-362. ISSN 0198-9715